share_log

What's Going On With Health Technology Company Masimo Shares Today?

What's Going On With Health Technology Company Masimo Shares Today?

麥斯莫醫療公司今天股票的表現如何?
Benzinga ·  12:26

Masimo Corporation (NASDAQ:MASI) shares are trading lower on Tuesday.

麥斯莫醫療公司(納斯達克:MASI)股票週二交易價格下跌。

Yesterday, Masimo reportedly disclosed that a potential joint venture partner is poised to bid between $850 million and $950 million for its consumer business encompassing health and audio products, reported Reuters.

據路透社報道,麥斯莫公司昨日披露一個潛在的合資夥伴準備以8500萬至9500萬美元之間的價格出價,收購其涵蓋健康和音頻產品的消費業務。

Masimo is currently engaged in active discussions with this unnamed partner regarding the joint venture terms, including Masimo's proposal to manage ongoing litigation outcomes with Apple Inc. (NASDAQ:AAPL).

目前,麥斯莫公司正在與這個未公佈的合作伙伴就合資條款進行積極討論,包括麥斯莫公司處理與蘋果公司(納斯達克:AAPL)的持續訴訟的建議。

Also Read: Masimo CEO 'Wholeheartedly' Feels Apple Watch Users Are Better Off Without Blood Oxygen Monitoring Feature

另外閱讀:麥斯莫CEO真心認爲Apple Watch用戶沒有血氧監測功能更好。

Today, the company disclosed the preliminary results for the second quarter of 2024.

今天,該公司公佈2024年第二季度的初步業績。

The company's consolidated revenue is expected to be approximately $496 million (street view stands at $493.56 million), representing 9% growth on a reported basis and 10% growth on a constant currency basis.

該公司的綜合營業收入預計爲大約4960萬美元(市場預期爲4935.6萬美元),同比上漲9%,不變貨幣基礎上同比增長10%。

Joe Kiani, Chairman and CEO of Masimo, stated, "We are excited to see the growth and strength of our healthcare business in the second quarter combined with a very strong order backlog as we enter the third quarter."

麥斯莫公司董事長兼首席執行官喬·基亞尼表示:“我們很高興看到第二季度我們的醫療保健業務增長和實力以及非常強的訂單積壓,當我們進入第三季度時。”

Masimo's healthcare revenue is expected to be approximately $344 million, representing 22% growth on a reported basis and 23% growth on a constant currency basis.

麥斯莫公司的醫療保健收入預計約爲3440萬美元,同比增長22%,不變貨幣基礎上同比增長23%。

Sensor utilization and hospital census have meaningfully improved from last year.

與去年相比,傳感器利用率和醫院人次明顯提高。

The company's non-healthcare revenue is expected to be approximately $152 million, representing a 13% decline on a reported basis and an 11% decline on a constant currency basis.

該公司的非醫療業務收入預計約爲1520萬美元,同比下降13%,不變貨幣基礎上同比下降11%。

"We achieved a record second quarter in terms of converting customers to our technologies with an expected $134 million of incremental contract value, which is the best sign of a healthy future for Masimo," Kiani added.

基亞尼補充道:“我們在第二季度轉換客戶到我們的技術上取得了創紀錄的業績,預計增值約爲1.34億美元,這是麥斯莫美好未來的最好跡象。”

Price Action: MASI shares are trading lower by 2.64% to $109.68 at last check Tuesday.

MASI股票週二最後交易價格爲109.68美元,下跌2.64%。

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

免責聲明:本內容部分使用人工智能工具生成,並經Benzinga編輯審核發佈。

  • XPeng CEO Says Tesla's FSD Works Well In Silicon Valley: '2025 Will Be The ChatGPT Moment Of Fully Self-Driving!'
  • 小鵬汽車CEO稱特斯拉的全自動駕駛系統在硅谷表現良好:“2025年將是chatgpt概念股的全自動駕駛時代!”
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論